{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:24:40Z","timestamp":1789352680416,"version":"build-2803163510"},"reference-count":38,"publisher":"Georg Thieme Verlag KG","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2013]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>\n          Streptococcus pneumoniae is a common causative pathogen of pneumonia and sepsis. Pneumonia and sepsis are associated with enhanced activation of coagulation, resulting in the production of several host-derived proteases at the primary site of infection and in the circulation. Serine proteases cleave protease activated receptors (PARs), which form a molecular link between coagulation and inflammation. PAR4 is one of four subtypes of PARs and is widely expressed by multiple cell types in the respiratory tract implicated in pulmonary inflammation, by immune cells and by platelets. In mice, mouse (m)PAR4 is the only thrombin receptor expressed by platelets. We here sought to determine the contribution of mPAR4 to the host response during pneumococcal pneumonia. Pneumonia was induced by intranasal inoculation with S. pneumoniae in mPAR4-deficient (par4-\/-\n          ) and wild-type mice. Mice were sacrificed after 6, 24 or 48 hours (h). Blood, lungs, liver and spleen were collected for analyses. Ex vivo stimulation assays were performed with S. pneumoniae and mPAR4 activating peptides. At 48 h after infection, higher bacterial loads were found in the lungs and blood of par4-\/-\n           mice (p &lt; 0.05), accompanied by higher histopathology scores and increased cytokine levels (p &lt; 0.05) in the lungs. Ex vivo, co-stimulation with mPAR4 activating peptide enhanced the whole blood cytokine response to S. pneumoniae. Thrombin inhibition resulted in decreased cytokine release after S. pneumoniae stimulation in human whole blood. Our findings suggest that mPAR4 contributes to antibacterial defence during murine pneumococcal pneumonia.<\/jats:p>","DOI":"10.1160\/th13-01-0052","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T11:18:20Z","timestamp":1371727100000},"page":"582-592","source":"Crossref","is-referenced-by-count":25,"title":["Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice"],"prefix":"10.1160","volume":"110","author":[{"given":"Cornelis","family":"van \u2019t Veer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florry E.","family":"van den Boogaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rienk","family":"Nieuwland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie J.","family":"Hoogendijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onno J.","family":"de Boer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris J. T. H.","family":"Roelofs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom van","family":"der Poll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha F.","family":"de Stoppelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2017,11,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(09)61114-4","article-title":"Pathogenesis, treatment, and prevention of pneumococcal pneumonia","volume":"374","author":"T van der Poll","year":"2009","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1378\/chest.12-0210","article-title":"Pneumococcal pneumonia: mechanisms of infection and resolution","volume":"142","author":"DH Dockrell","year":"2012","journal-title":"Chest"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1473-3099(02)00316-X","article-title":"Treatment of drug-resistant pneumococcal pneumonia","volume":"02","author":"J Garau","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"S 04","key":"ref4","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1097\/01.CCM.0000057849.53689.65","article-title":"Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia","volume":"31","author":"M Levi","year":"2003","journal-title":"Crit Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.it.2007.09.001","article-title":"Protease-activated receptors: novel PARtners in innate immunity","volume":"28","author":"V Shpacovitch","year":"2007","journal-title":"Trends Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1476-5381.2009.00449.x","article-title":"Protease-activated receptors and prostaglandins in inflammatory lung disease","volume":"158","author":"T Peters","year":"2009","journal-title":"Br J Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.pharmthera.2007.04.002","article-title":"A novel therapeutic target in various lung diseases: airway proteases and protease-activated receptors","volume":"115","author":"E Sokolova","year":"2007","journal-title":"Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.lfs.2007.06.026","article-title":"Protease-activated receptor 4-mediated Ca2+ signaling in mouse lung alveolar epithelial cells","volume":"81","author":"S Ando","year":"2007","journal-title":"Life Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1465-9921-8-31","article-title":"Proteinase-activated receptor 4 stimulation-induced epithelial-mesenchymal transition in alveolar epithelial cells","volume":"08","author":"S Ando","year":"2007","journal-title":"Respir Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.4049\/jimmunol.169.3.1467","article-title":"Characterization of thrombin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4","volume":"169","author":"N Vergnolle","year":"2002","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.bjp.0705926","article-title":"Effects of inhaled thrombin receptor agonists in mice","volume":"143","author":"JD Moffatt","year":"2004","journal-title":"Br J Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/29325","article-title":"A dual thrombin receptor system for platelet activation","volume":"394","author":"ML Kahn","year":"1998","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2003-04-1130","article-title":"Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells","volume":"102","author":"H Kataoka","year":"2003","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1369\/jhc.4A6592.2005","article-title":"Activation of PAR4 induces a distinct actin fiber formation via p38 MAPK in human lung endothelial cells","volume":"53","author":"M Fujiwara","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1476-5381.2010.00705.x","article-title":"Signal transduction by protease-activated receptors","volume":"160","author":"UJ Soh","year":"2010","journal-title":"Br J Pharmacol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.CCM.0000218807.20570.C2","article-title":"Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia","volume":"34","author":"AW Rijneveld","year":"2006","journal-title":"Crit Care Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1538-7836.2010.04089.x","article-title":"Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia","volume":"09","author":"FE Van Den Boogaard","year":"2011","journal-title":"J Thromb Haemost"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1182\/blood-2003-01-0227","article-title":"Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia","volume":"102","author":"AW Rijneveld","year":"2003","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1128\/IAI.05593-11","article-title":"Cathepsin G and neutrophil elastase play critical and nonredundant roles in lung-protective immunity against Streptococcus pneumoniae in mice","volume":"79","author":"I Hahn","year":"2011","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/35092573","article-title":"Role of thrombin signalling in platelets in haemostasis and thrombosis","volume":"413","author":"GR Sambrano","year":"2001","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/infdis\/jis615","article-title":"CCAAT-enhancer binding protein delta (C\/EBPdelta) protects against Klebsiella pneumoniae-induced pulmonary infection: potential role for macrophage migration","volume":"206","author":"J Duitman","year":"2012","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.imbio.2011.02.004","article-title":"Enhanced vulnerability for Streptococcus pneumoniae sepsis during asplenia is determined by the bacterial capsule","volume":"216","author":"AJ Lammers","year":"2011","journal-title":"Immunobiology"},{"key":"ref23","first-page":"237","article-title":"Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci","volume":"10","author":"MC Dessing","year":"2008","journal-title":"Cell Microbiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1440-1843.2010.01814.x","article-title":"Pneumococci: immunology of the innate host response","volume":"15","author":"GK Paterson","year":"2010","journal-title":"Respirology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1189\/jlb.0607373","article-title":"Inflammation, endothelium, and coagulation in sepsis","volume":"83","author":"M Schouten","year":"2008","journal-title":"J Leukoc Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/381516a0","article-title":"Role of the thrombin receptor in development and evidence for a second receptor","volume":"381","author":"AJ Connolly","year":"1996","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1055\/s-0038-1648926","article-title":"Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides","volume":"72","author":"TM Connolly","year":"1994","journal-title":"Thromb Haemost"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.4049\/jimmunol.168.7.3577","article-title":"Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells","volume":"168","author":"N Asokananthan","year":"2002","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1182\/blood-2007-02-075440","article-title":"Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation","volume":"110","author":"SH Slofstra","year":"2007","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.bjp.0703776","article-title":"Role of PGE(2) in protease-activated receptor-1, -2 and -4 mediated relaxation in the mouse isolated trachea","volume":"132","author":"RS Lan","year":"2001","journal-title":"Br J Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"JW Semple","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00018-009-0210-4","article-title":"Platelets in defense against bacterial pathogens","volume":"67","author":"MR Yeaman","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1128\/IAI.70.12.6524-6533.2002","article-title":"Antimicrobial peptides from human platelets","volume":"70","author":"YQ Tang","year":"2002","journal-title":"Infect Immun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2010-08-301424","article-title":"Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia","volume":"117","author":"K Krauel","year":"2011","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.ATV.0000031340.68494.34","article-title":"Platelets and thrombin generation","volume":"22","author":"DM Monroe","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.4049\/jimmunol.175.4.2598","article-title":"Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms","volume":"175","author":"X Su","year":"2005","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1183\/09031936.00045812","article-title":"Protease-activated receptor-4 deficiency does not protect against bleomycin-induced pulmonary fibrosis in mice","volume":"40","author":"K Borensztajn","year":"2012","journal-title":"Eur Respir J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"R238.","DOI":"10.1186\/cc11910","article-title":"Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study","volume":"16","author":"M Schouten","year":"2012","journal-title":"Crit Care"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1160\/TH13-01-0052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:02:44Z","timestamp":1685534564000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1160\/TH13-01-0052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":38,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2017,11,29]]},"published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1160\/th13-01-0052","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}